Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii
Clinical and Experimental Vaccine Research · 2020 · 9 (2) · 81
DOI: 10.7774/cevr.2020.9.2.81 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Vaccine Research, 2020. Verfasst von Ali Dalir Ghaffari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Iran National Science Foundation, Tarbiat Modares University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
ORCID-Profile: Ali Dalir Ghaffari, Abdolhossein Dalimi, Fatemeh Ghaffarifar, Majid Pirestani
Förderung
- Iran National Science Foundation
- Tarbiat Modares University
Zitieren
APA
Ghaffari, A. D., Dalimi, A., Ghaffarifar, F., & Pirestani, M. (2020). Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii. Clinical and Experimental Vaccine Research, 9(2), 81. https://doi.org/10.7774/cevr.2020.9.2.81
Vancouver
Ghaffari AD, Dalimi A, Ghaffarifar F, Pirestani M. Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii. Clinical and Experimental Vaccine Research. 2020;9(2):81. doi:10.7774/cevr.2020.9.2.81
BibTeX
@article{Ghaffari2020,
author = {Ghaffari, Ali Dalir and Dalimi, Abdolhossein and Ghaffarifar, Fatemeh and Pirestani, Majid},
title = {Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii},
journal = {Clinical and Experimental Vaccine Research},
year = {2020},
volume = {9},
number = {2},
pages = {81},
doi = {10.7774/cevr.2020.9.2.81}
}
EUVIMED